EQL Pharma AB (publ) (STO:EQL)
91.90
-4.80 (-4.96%)
At close: Aug 1, 2025
EQL Pharma AB Employees
EQL Pharma AB had 21 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
17.79M SEK
Profits / Employee
2.05M SEK
Market Cap
2.67B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 21 | 0 | - |
Mar 31, 2024 | 21 | 3 | 16.67% |
Mar 31, 2023 | 18 | 5 | 38.46% |
Mar 31, 2022 | 13 | 3 | 30.00% |
Mar 31, 2021 | 10 | 2 | 25.00% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,296 |
Getinge AB | 11,791 |
Camurus AB | 256 |
Medicover AB | 47,256 |
Asker Healthcare Group AB | 4,030 |
Bonesupport Holding AB | 139 |
AddLife AB | 2,181 |